๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Cancer of Rectum

SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC NCT07284992Phase 21 site๐Ÿ“ Jinan Shandong Provincial Hospital ยท Tests: short-term radiotherapy combined with Adebrelimab and capox, long-term radiotherapy combined with Adebrelimab and capox Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer NCT06928584Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: Conventional Radiotherapy, Capecitabine, 5-fluorouracil, folinic acid, Oxaliplatin Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease NCT06607458Phase 220 sites๐Ÿ“ Duarte๐Ÿ“ Santa Monica๐Ÿ“ Miami Delcath Systems Inc. ยท Tests: Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab, Trifluridine-tipiracil โ€ฆ A Study of Tucatinib and Trastuzumab in People With Rectal Cancer NCT05672524Phase 27 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Trastuzumab, Tucatinib Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer NCT07352280n/a1 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps NCT05080673NA493 sites๐Ÿ“ Fairbanks๐Ÿ“ Goodyear๐Ÿ“ Kingman NRG Oncology ยท Tests: 5-year and 10 Year Surveillance Colonoscopy after Qualifying Colonoscopy Organ Preservation in Locally Advanced Rectal Cancer NCT03064646NA1 site๐Ÿ“ Elche Fundaciรณn para el Fomento de la Investigaciรณn Sanitaria y Bโ€ฆ ยท Tests: Organ Preservation Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 NCT07595874Phase 211 sites๐Ÿ“ Goodyear๐Ÿ“ Corona๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Balstilimab, Biospecimen Collection, Botensilimab, Computed Tomography, Magnetic Resonance Imaging Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer. NCT06940388Phase 22 sites๐Ÿ“ Mainz๐Ÿ“ Petah Tikva brenner baruch ยท Tests: Tislelizumab, Total neoadjuvant therapy (TNT) Colorectal Metastasis Prevention International Trial 2 NCT03919461Phase 26 sites๐Ÿ“ Afula๐Ÿ“ Haifa๐Ÿ“ Petah Tikva Assaf-Harofeh Medical Center ยท Tests: Propranolol and etodolac, Placebo MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer NCT06840665Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: PD-1 antibody, Oxaliplatin, Capecitabine Efficacy and Safety of Trastuzumab Biosimilars and Pertuzumab Biosimilars Combined With Chemotherapy for Neoadjuvant Treatment of Patients With Locally Advanced HER2-positive Rectal Cancer NCT07108127Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Trastuzumab biosimilars and pertuzumab biosimilars plus XELOX Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery NCT07881133NA1 site๐Ÿ“ Bucharest Bucharest Emergency Hospital ยท Tests: Perioperative Biomarker-Guided Monitoring Application of PET/MRI in the Evaluation of the Efficacy of Neoadjuvant Therapy for Locally Advanced Rectal Cancer NCT06653452NA1 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: 18F-FDG PET/CT and PET/MR scan, 68Ga-FAPI-04 PET/CT and PET/MR scan Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits NCT03303547NA1 site๐Ÿ“ London Imperial College London ยท Tests: MRI mapping to guide pathological sampling of extranodal tumour deposits Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Shanghai GV20 Therapeutics ยท Tests: GV20-0251 A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks NCT07469709n/a1 site๐Ÿ“ Candiolo Fondazione del Piemonte per l'Oncologia Comparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer NCT05943444NA1 site๐Ÿ“ Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University ยท Tests: Parks technique, Bacon technique To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer NCT06808412Phase 21 site๐Ÿ“ Xi'an xiaohua li ยท Tests: sintilimab combined with bevacizumab and XELOX UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer NCT05148767Phase 41 site๐Ÿ“ Hangzhou Zhejiang Cancer Hospital ยท Tests: Neoadjuvant chemoradiotherapy based on irinotecan Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer NCT07528209Phase 31 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Pucotenlimab combine with CAPOX, CAPOX Treating Locally Advanced Rectal Cancer With TAS-102 Chemotherapy Plus Neoadjuvant Radiotherapy NCT05965531Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Trifluridine/Tipiracil, intensity-modulated radiotherapy Short-course Radiotherapy Followed by Sequential Chemotherapy With or Without PD-1 Monoclonal Antibody and Bevacizumab as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer ๏ผˆSPARK๏ผ‰ NCT07005570Phase 21 site๐Ÿ“ Guangzhou Dechang Diao ยท Tests: Short-course radiotherapy followed by sequential chemotherapy combined with PD-1 monoclonal antibody and bevacizumab, Sโ€ฆ Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer NCT04743102NA1 site๐Ÿ“ Beijing Beijing Chao Yang Hospital ยท Tests: multi-points and full-thickness Biopsy, traditional cCR Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer NCT06949098Phase 21 site๐Ÿ“ Shijiazhuang Hebei Medical University Fourth Hospital ยท Tests: Local Tumor Resection, Radiotherapy, Chemotherapy Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I) NCT06923345Phase 21 site๐Ÿ“ Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University ยท Tests: Reduced CTV, Conventional CTV Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery NCT04103372NA23 sites๐Ÿ“ Reading๐Ÿ“ Amersham๐Ÿ“ London Imperial College London ยท Tests: MRI scan, Radiologist training Beyond TME Origins NCT02292641NA4 sites๐Ÿ“ Oslo๐Ÿ“ Harrow๐Ÿ“ Oxford Imperial College London ยท Tests: New Radiological Staging Classification system for patients with advanced and recurrent colorectal cancer undergoing peโ€ฆ Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors NCT07145255Phase 1, Phase 27 sites๐Ÿ“ San Francisco๐Ÿ“ Grand Rapids๐Ÿ“ East Brunswick MBrace Therapeutics ยท Tests: ADC Prehabilitation in High-risk Oncologic Surgery NCT07638410NA1 site๐Ÿ“ Philadelphia Fox Chase Cancer Center ยท Tests: Multidisciplinary Prehabilitation Program
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy